CVS Caremark agreed to pay $5 million to settle charges brought by the Federal Trade Commission.  The FTC accused the company of misrepresenting the price of certain prescription drugs in one of its Medicare drug plans.    This misrepresentation caused many older consumers to pay prices that were significantly higher than advertised.  CVS Caremark runs prescription drug plans for employers and...